These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7632972)

  • 21. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
    Borgmann A; Hartmann R; Schmid H; Klingebiel T; Ebell W; Göbel U; Peters C; Gadner H; Henze G
    Bone Marrow Transplant; 1995 Apr; 15(4):515-21. PubMed ID: 7655375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remission.
    Ganem G; Kuentz M; Bernaudin F; Gharbi A; Cordonnier C; Lemerle S; Karianakis G; Vinci G; Rochant H; Lebourgeois JP
    Cancer; 1989 Nov; 64(9):1796-804. PubMed ID: 2676139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study.
    Boulad F; Steinherz P; Reyes B; Heller G; Gillio AP; Small TN; Brochstein JA; Kernan NA; O'Reilly RJ
    J Clin Oncol; 1999 Jan; 17(1):197-207. PubMed ID: 10458234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocol.
    Giona F; Annino L; Rondelli R; Arcese W; Meloni G; Testi AM; Moleti ML; Amadori S; Resegotti L; Tabilio A; Ladogana S; Fioritoni G; Camera A; Liso V; Leoni P; Mandelli F
    Br J Haematol; 1997 Jun; 97(4):896-903. PubMed ID: 9217194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
    Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
    Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of low-dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation.
    Soiffer RJ; Murray C; Gonin R; Ritz J
    Blood; 1994 Aug; 84(3):964-71. PubMed ID: 8043878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group.
    Borgmann A; Schmid H; Hartmann R; Baumgarten E; Hermann K; Klingebiel T; Ebell W; Zintl F; Gadner H; Henze G
    Lancet; 1995 Sep; 346(8979):873-6. PubMed ID: 7564672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA-typing.
    Ljungman P; de Witte T; Verdonck L; Gahrton G; Freycon F; Gravett P; McCann S; Morgenstern HG; Nikoskelainen J; Powles R
    Br J Haematol; 1993 May; 84(1):61-6. PubMed ID: 8338779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission.
    Woods WG; Neudorf S; Gold S; Sanders J; Buckley JD; Barnard DR; Dusenbery K; DeSwarte J; Arthur DC; Lange BJ; Kobrinsky NL;
    Blood; 2001 Jan; 97(1):56-62. PubMed ID: 11133742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group].
    Hübner G; Link H; Schönrock-Nabulsi P; Wandt H; Gramatzki M; Löffler B; Fackler-Schwalbe I; Queisser W; Brack N; Geer T; Raab M; Ohl S; Schneider B; Schneider C; Freund M; Poliwoda H; Ehninger G
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():26-32. PubMed ID: 8692115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bone marrow transplantation versus maintenance chemotherapy for adult acute leukemia in first remission].
    Suzuki R; Iida H; Taji H; Murata M; Sugihara T; Minami S; Kodera Y
    Rinsho Ketsueki; 1996 Dec; 37(12):1362-70. PubMed ID: 8997123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic bone marrow transplantation versus chemotherapy in high-risk childhood acute lymphoblastic leukaemia in first remission. Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) and the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Uderzo C; Valsecchi MG; Balduzzi A; Dini G; Miniero R; Locatelli F; Rondelli R; Pession A; Arcese W; Bacigalupo A; Polchi P; Andolina M; Messina C; Conter V; Aricó M; Galimberti S; Masera G
    Br J Haematol; 1997 Feb; 96(2):387-94. PubMed ID: 9029031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission.
    Tiedemann K; Waters KD; Tauro GP; Tucker D; Ekert H
    Blood; 1993 Dec; 82(12):3730-8. PubMed ID: 8260710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy.
    Thomas X; Le Q; Botton Sd; Raffoux E; Chelghoum Y; Pautas C; Dreyfus F; Dhedin N; Vekhoff A; Troncy J; Pigneux A; Revel Td; Reman O; Travade P; Thiebaut A; Guerci A; Elhamri M; Fenaux P; Dombret H; Michallet M
    Leuk Lymphoma; 2005 Jul; 46(7):1007-16. PubMed ID: 16019551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous bone marrow transplantation vs intensive chemotherapy in first complete remission: interim results of GOELAM study in AML.
    Harousseau JL; Pignon B; Dufour P; Ifrah N; Solary E; Abgrall JF; Milpied N; Desablens B; Guyotat D; Herve P
    Leukemia; 1992; 6 Suppl 2():120-3. PubMed ID: 1578912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma.
    Levine JE; Harris RE; Loberiza FR; Armitage JO; Vose JM; Van Besien K; Lazarus HM; Horowitz MM; Bashey A; Bolwell BJ; Burns LJ; Cairo MS; Champlin RE; Freytes CO; Gibson J; Goldstein SC; Laughlin MJ; Lister J; Marks DI; Maziarz RT; Miller AM; Milone GA; Pavlovsky S; Pecora AL; Rizzo JD; Schiller G; Schouten HC; Zhang MJ;
    Blood; 2003 Apr; 101(7):2476-82. PubMed ID: 12456505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hematopoietic stem cell transplantation for treatment of acute leukemia].
    Harada M
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1387-95. PubMed ID: 10500524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-2 therapy after allogeneic bone marrow transplantation for acute myelocytic leukemia: studies in a relevant rat model for AML.
    Kloosterman TC; Martens AC; Osterwalder B; Hagenbeek A
    Bone Marrow Transplant; 1994 Dec; 14(6):965-73. PubMed ID: 7711675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.